As the deputy director for scientific work of the Central Research Institute of Epidemiology of Rospotrebnadzor, Alexander Gorelov, explained to the media, healthy volunteers should be vaccinated at the stage of clinical trials.
According to the expert, the concealment of diseases threatens the development of undesirable reactions and side effects. At the same time, a slight increase in body temperature, local redness at the injection site is a normal reaction to the administration of the vaccine, Gorelov pointed out.
"In the annotation for the drug there is always a description of such possible effects," – quotes the specialist RIA Novosti.
Recall that in August, the Ministry of Health of Russia registered the world's first vaccine for the prevention of COVID-19, developed by the Gamaleya Research Center for Electrochemistry and Technology, and produced in conjunction with the Russian Direct Investment Fund. It got the name "Sputnik V" – by analogy with the launch of the first artificial Earth satellite. The vaccine involves the introduction of two components of the drug with an interval of three weeks.
The vaccine can enter civilian circulation from January 1, 2021. The Ministry of Health added that after vaccination, immunity to COVID-19 can persist for up to two years.
In the subject, Russian President Vladimir Putin announced the registration of the second domestic vaccine against coronavirus and the imminent registration of the third, writes TASS.
According to the head of state, in order to combat the spread of coronavirus, it is important to increase the production of Russian vaccines, as well as to ensure their availability in the country's domestic market.